샘플 요청 목록

 카트 문의
시장보고서
상품코드
2156154

혈액 배양 검사 시장

Blood Culture Tests
발행일: | 리서치사: 구분자 Market Glass, Inc. | 페이지 정보: 영문 471 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 파일 내 텍스트의 복사 및 붙여넣기는 가능하지만, 표/그래프 등은 복사할 수 없습니다. 인쇄는 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 5,850 금액 안내 화살표 ￦ 7,905,000
PDF & Excel (Team License: Up to 10 users) help
PDF & Excel 보고서를 동일 기업 내 최대 10명까지 이용할 수 있는 라이선스입니다. 파일 내 텍스트의 복사 및 붙여넣기가 가능하지만, 표/그래프 등은 복사할 수 없습니다. 인쇄는 이용자 1명당 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 11,115 금액 안내 화살표 ￦ 15,019,000
PDF & Excel (Global License to Company and its Fully-owned Subsidiaries) help
PDF & Excel 보고서를 동일 기업 및 100% 자회사의 모든 분이 이용하실 수 있는 라이선스입니다. 인쇄는 1인당 1회 가능하며, 인쇄물의 이용범위는 파일 이용범위와 동일합니다.
US $ 17,550 금액 안내 화살표 ￦ 23,715,000
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계 혈액 배양 검사 시장은 2032년까지 148억 달러에 달할 전망

2025년 64억 달러로 추산되는 세계 혈액 배양 검사 시장은 2025-2032년의 분석 기간 동안 연평균 성장률(CAGR) 12.6%를 기록하며, 2032년까지 148억 달러에 달할 것으로 예측됩니다. 본 보고서에서 분석 대상으로 삼고 있는 부문 중 하나인 ‘소모품’은 연평균 성장률(CAGR) 14.6%를 기록하며, 분석 기간이 끝날 때까지 76억 달러에 달할 것으로 예측됩니다. ‘장비’ 부문의 성장률은 분석 기간 동안 연평균 성장률(CAGR) 9.9%를 나타낼 것으로 추정됩니다.

미국 시장은 18억 달러로 추산되는 반면, 중국은 연평균 성장률(CAGR) 16.8%를 나타낼 것으로 예측됩니다.

미국의 혈액 배양 검사 시장은 2025년에 18억 달러로 추산됩니다. 세계 2위의 경제 규모를 자랑하는 중국은 2025-2032년의 분석 기간 동안 연평균 성장률(CAGR) 16.8%를 기록하며, 2032년까지 시장 규모가 32억 달러에 달할 것으로 예측됩니다. 그 밖의 주목할 만한 지역 시장으로는 일본과 캐나다가 꼽히며, 분석 기간 동안 각각 연평균 성장률(CAGR) 9.3% 및 11.6%를 나타낼 것으로 예측됩니다. 유럽 내에서는 독일이 연평균 성장률(CAGR) 약 10.2%를 나타낼 것으로 예측됩니다.

세계 혈액 배양 검사 시장 - 주요 동향 및 촉진요인 개요

왜 혈액 배양 검사는 현대 의료에서 필수적인 것일까？

혈액 배양 검사는 균혈증이나 패혈증과 같은 중증 혈류 감염의 진단 및 관리에 있어 기초가 되는 검사입니다. 이러한 검사에서는 환자의 혈액 검체를 채취하여 배양을 통해 세균이나 진균 등 유해한 미생물의 존재를 검출하고 동정합니다. 병원체가 검출되면, 그 정확한 유형을 파악하고 항생제 내성을 판정하기 위해 추가 검사가 수행됩니다. 혈액 배양 검사의 중요성은 아무리 강조해도 지나치지 않습니다. 중증 감염증의 진단, 효과적인 항생제 치료의 지침, 그리고 감염증이 패혈증과 같은 생명을 위협하는 상태로 악화되는 것을 방지하는 데 있어 지극히 중요한 역할을 하고 있기 때문입니다. 감염증을 신속하고 정확하게 파악하는 것은 의료진이 적절한 치료를 시작하는 데 필수적이며, 환자의 예후를 크게 개선하고 합병증의 위험을 줄여줍니다.

기술 혁신은 지금까지 혈액 배양 검사를 어떻게 변화시켜 왔을까？

혈액 배양 검사 분야는 수작업으로 시간이 많이 소요되던 방식에서 고도로 자동화된 신속한 진단 과정으로 진화하며 비약적인 발전을 이루었습니다. 과거에는 혈액 배양물을 배지에서 배양하고 미생물의 증식을 수작업으로 관찰했으나, 이 방법으로는 결과가 나오기까지 며칠이 걸리기도 했습니다. 이 과정은 검체를 지속적으로 모니터링하고 증식을 더 신속하고 정확하게 감지하는 자동 혈액 배양 시스템의 도입으로 혁명적인 변화를 맞이했습니다. 이러한 진보로 인해 진단에 필요한 시간이 대폭 단축되어 더 조기적인 개입이 가능해졌습니다. 또한 최근에는 분자진단과 병원체 신속 동정 기술의 통합으로 진단 과정이 더욱 가속화되고 있습니다. 이러한 혁신 덕분에 불과 몇 시간 만에 병원체를 검출하고 항생제 내성을 판정할 수 있게 되어, 의료진은 더 신속하고 정확한 치료 결정을 내릴 수 있게 되었습니다. 그 결과, 환자 치료의 질이 향상되고 혈류 감염으로 인한 사망률이 감소하고 있습니다.

혈액 배양 검사의 미래를 형성할 최신 동향은 무엇일까？

혈액 배양 검사 분야는 현재, 진단의 정확도와 속도 향상을 약속하는 몇 가지 중요한 동향과 혁신에 의해 재편되고 있습니다. 가장 영향력 있는 동향 중 하나는 기존의 혈액 배양 검사 기법에 분자진단 기술을 접목하는 것입니다. 중합효소 연쇄반응(PCR)이나 차세대 염기서열 분석(NGS)과 같은 기술이 많은 경우 배양이 이루어지기 전에 혈액 검체에서 직접 병원체를 검출하는 데 활용되어, 진단까지 걸리는 시간을 획기적으로 단축하고 있습니다. 또한, 현장 진단(POC) 혈액 배양 검사 기기 개발을 위한 움직임도 활발해지고 있습니다. 이러한 기기는 환자의 병상이나 원격지에서도 신속한 결과를 제공하여, 기존의 실험실 인프라가 제한된 곳에서도 중요한 진단에 대한 접근성을 개선하고 있습니다. 또한, 생물정보학과 인공지능(AI)의 통합을 통해 혈액 배양 결과의 해석이 개선되고, 병원체 동정 정확도가 높아지며, 항생제 내성 예측 정확도도 향상되고 있습니다. 이러한 진보는 혈액 배양 검사의 가능성을 넓혀, 보다 개인 맞춤형의 효과적인 치료 전략을 실현할 가능성을 열어주고 있습니다.

혈액 배양 검사 시장의 성장을 견인하는 주요 시장 성장 촉진요인은 무엇일까？

혈액 배양 검사 시장의 성장은 의료 현장에서 조기 및 정확한 감염증 진단의 중요성이 커지고 있음을 보여주는 몇 가지 중요한 요인에 의해 주도되고 있습니다. 혈류 감염 및 패혈증 발생률 증가로 인해 신뢰성 높고 신속한 진단 검사에 대한 절실한 필요성이 대두되면서, 혈액 배양 기술에 대한 수요를 뒷받침하고 있습니다. 또한, 다제내성균의 확산으로 인해 병원체와 그 내성 패턴을 정확하게 규명하는 것이 필수적이 되었으며, 이는 첨단 혈액 배양 검사 시장의 추가적인 확장을 뒷받침하고 있습니다. 더 신속하고 정확한 결과를 제공하는 자동화 및 분자진단 시스템의 도입 또한 시장 성장의 또 다른 주요 촉진요인입니다. 이에 더해, 신흥 시장의 의료 인프라 확충으로 인해 세계 더 많은 의료시설에서 첨단 진단 능력을 이용할 수 있게 되고 있습니다. 또한, 의료 종사자들 사이에서 패혈증 조기 발견의 중요성에 대한 인식이 높아지고, 견고한 패혈증 관리 프로토콜이 도입되고 있는 점도 혈액 배양 검사의 이용 확대에 크게 기여하고 있습니다. 이러한 요인들이 복합적으로 작용하여 혈액 배양 검사 시장을 견인하고 있으며, 현대 감염병 관리 및 환자 치료에서 이 시장이 중심적인 역할을 수행할 것임을 확고히 하고 있습니다.

부문:

제품 및 서비스(소모품, 기기, 소프트웨어 및 서비스), 기술(배양법, 분자 기술, 단백질체학 기술), 용도(세균 감염증, 진균 감염증, 마이코박테리아 감염증), 최종 용도(병원 검사실, 참조 검사실, 기타)

주요 기업

  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bruker Corporation
  • Cepheid, Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • F. Hoffmann-La Roche Ltd.
  • Terumo Corporation
  • Thermo Fisher Scientific, Inc.
  • ZeptoMetrix

해당 분야의 전문가 관점을 바탕으로 합니다. 산업계, 기업, 학계에 걸친 분야 전문가들의 관점을 반영하여, 기존에 발표된 조사 결과 이상의 맥락을 더하고 있습니다.

시장의 초기 신호를 포착합니다 - 기존의 2차 조사에 완전히 반영되기 전에, 전문가 간의 대화, 기업의 동향, 시장과 관련된 논의를 통해 드러나는 변화를 추적합니다.

광범위하고 검증된 정보 기반을 활용합니다-컨퍼런스 세션, 기조 연설, 패널 토론, 블로그, 기업 공시 정보, 연차 보고서, 기관 간행물 및 기타 검증된 정보원에서 얻은 인사이트를 통합하고 있습니다.

신호와 전략적 시장 방향성을 연결합니다 - 이러한 관점을 통합하여 시장이 어디로 향하고 있는지, 그 움직임을 주도하는 요인은 무엇인지, 그리고 전략에 있어 가장 중요할 가능성이 있는 동향은 무엇인지 파악합니다.

상세한 기업 정보를 제공합니다 - 시장 수준의 분석에 그치지 않고, 경쟁 환경에 참여하며 그 형성에 기여하고 있는 기업을 상세하게 검증합니다.

주요 지역 시장 점유율을 면밀히 검토합니다 - 단일 세계 시장 점유율 수치만으로는 전체적인 상황을 파악하기 어렵습니다. 경쟁 구도는 지역에 따라 크게 다를 수 있습니다. 분석상 관련성이 있는 경우, Market Glass의 보고서는 각 시장의 구조와 동향에 맞추어 상세도를 조정하여 주요 지역 시장 점유율 분석을 심층적으로 다룹니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 26.10.29

Global Blood Culture Tests Market to Reach US$14.8 Billion by 2032

The global market for Blood Culture Tests estimated at US$6.4 Billion in the year 2025, is expected to reach US$14.8 Billion by 2032, growing at a CAGR of 12.6% over the analysis period 2025-2032. Consumables Offering, one of the segments analyzed in the report, is expected to record a 14.6% CAGR and reach US$7.6 Billion by the end of the analysis period. Growth in the Instruments Offering segment is estimated at 9.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.8 Billion While China is Forecast to Grow at 16.8% CAGR

The Blood Culture Tests market in the U.S. is estimated at US$1.8 Billion in the year 2025. China, the world's second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2032 trailing a CAGR of 16.8% over the analysis period 2025-2032. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 9.3% and 11.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 10.2% CAGR.

Global Blood Culture Tests Market - Key Trends and Drivers Summarized

Why Are Blood Culture Tests Indispensable in Modern Healthcare?

Blood culture tests are a cornerstone in the diagnosis and management of serious bloodstream infections like bacteremia and septicemia. These tests involve taking a patient’s blood sample and cultivating it to detect and identify the presence of harmful microorganisms such as bacteria or fungi. Once a pathogen is detected, additional testing is conducted to pinpoint the exact type and determine its antibiotic resistance. The importance of blood culture tests cannot be overstated, as they are critical in diagnosing severe infections, guiding effective antibiotic therapy, and preventing the escalation of infections into life-threatening conditions like sepsis. Timely and accurate identification of infections is essential for healthcare providers to initiate appropriate treatments, significantly improving patient outcomes and reducing the risk of complications.

How Have Innovations Transformed Blood Culture Testing Over Time?

The field of blood culture testing has seen profound advancements, evolving from manual, time-consuming methods to highly automated, rapid diagnostic processes. In the past, blood cultures were incubated in broth media and manually observed for microbial growth, a method that could take several days to yield results. This process has been revolutionized by the introduction of automated blood culture systems, which continuously monitor samples and detect growth more quickly and accurately. These advancements have significantly reduced the time required for diagnosis, allowing for earlier intervention. More recently, the integration of molecular diagnostics and rapid pathogen identification technologies has further accelerated the diagnostic process. These innovations allow for the detection of pathogens and determination of antibiotic resistance in just hours, enabling healthcare providers to make faster, more informed treatment decisions, ultimately improving patient care and reducing mortality from bloodstream infections.

What Are the Latest Trends Shaping the Future of Blood Culture Testing?

The blood culture testing landscape is currently being reshaped by several key trends and innovations that promise to enhance diagnostic accuracy and speed. One of the most impactful trends is the incorporation of molecular diagnostics into traditional blood culture methodologies. Techniques like polymerase chain reaction (PCR) and next-generation sequencing (NGS) are being used to detect pathogens directly from blood samples, often before they can be cultured, drastically cutting down the time to diagnosis. Additionally, there is a growing movement toward the development of point-of-care (POC) blood culture testing devices, which provide rapid results at the patient’s bedside or in remote areas, improving access to critical diagnostics where traditional lab infrastructure is limited. Moreover, the integration of bioinformatics and artificial intelligence (AI) is enhancing the interpretation of blood culture results, leading to more accurate pathogen identification and better predictions of antibiotic resistance. These advancements are pushing the boundaries of what is possible in blood culture testing, offering the potential for more personalized and effective treatment strategies.

What Are the Main Drivers Fueling Growth in the Blood Culture Testing Market?

The growth in the blood culture testing market is driven by several critical factors that highlight the increasing role of early and precise infection diagnosis in healthcare. The rising incidence of bloodstream infections and sepsis has created a pressing need for reliable and timely diagnostic tests, driving demand for blood culture technologies. Additionally, the growing prevalence of multidrug-resistant organisms has made it essential to accurately identify pathogens and their resistance patterns, further boosting the market for advanced blood culture tests. The adoption of automated and molecular diagnostic systems, which offer quicker and more precise results, is another major driver of market growth. This is complemented by the expansion of healthcare infrastructure in emerging markets, which is bringing advanced diagnostic capabilities to more facilities worldwide. Furthermore, increased awareness among healthcare professionals about the importance of early sepsis detection and the implementation of robust sepsis management protocols are significantly contributing to the rising use of blood culture tests. Together, these factors are propelling the blood culture testing market forward, ensuring its central role in modern infection management and patient care.

SCOPE OF STUDY:

The report analyzes the Blood Culture Tests market by the following Segments, and Geographic Regions/Countries:

Segments:

Offering (Consumables Offering, Instruments Offering, Software & Services Offering); Technology (Culture-based Technology, Molecular Technology, Proteomic Technology); Application (Bacterial Infections Application, Fungal Infections Application, Mycobacterial Infections Application); End-Use (Hospital Laboratories End-Use, Reference Laboratories End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

SELECT PLAYERS -

  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • bioMerieux SA
  • Bruker Corporation
  • Cepheid, Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • F. Hoffmann-La Roche Ltd.
  • Terumo Corporation
  • Thermo Fisher Scientific, Inc.
  • ZeptoMetrix

WHAT SETS THIS REPORT APART FROM OTHERS?

Grounded in Domain Expert Perspectives - Incorporates perspectives emerging from domain experts across industry, enterprise and academia, adding context beyond conventional published research.

Captures Early Market Signals - Tracks shifts emerging through expert conversations, company activity and market-relevant discussions before they are fully reflected in traditional secondary research.

Draws From a Broad, Validated Intelligence Base - Brings together insights from conference sessions, keynotes, panel discussions, blogs, corporate disclosures, annual reports, institutional publications and other validated sources.

Connects Signals With Strategic Market Direction - Synthesizes these perspectives to identify where the market is moving, what is driving that movement and which developments are likely to matter most for strategy.

Provides In-Depth Company Intelligence - Extends beyond market-level analysis to examine the companies participating in and shaping the competitive environment.

Market Share Is Examined Where It Matters - A single global market share figure rarely tells the full story. Competitive structures can vary significantly across geographies. Where analytically relevant, Market Glass reports extend market share analysis into major regions with the level of detail tailored to the structure and dynamics of each market.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Blood Culture Tests - Global Key Competitors Percentage Market Share in 2026 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for 42 Players Worldwide in 2026 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Incidence of Bloodstream Infections Throws the Spotlight on the Need for Advanced Blood Culture Tests
    • Increasing Prevalence of Sepsis Drives Demand for Rapid and Accurate Blood Culture Diagnostics
    • Advancements in Molecular Diagnostics Propel Growth in Early Detection Technologies for Blood Infections
    • Innovations in Automated Blood Culture Systems Accelerate Demand for High-Efficiency Diagnostics
    • Expansion of Point-of-Care Testing Spurs Growth in Portable and Rapid Blood Culture Devices
    • Integration of Artificial Intelligence in Diagnostics Drives Adoption of Smart Blood Culture Systems
    • Rising Demand for Faster Turnaround Times Sustains Growth in Rapid Blood Culture Test Development
    • Innovations in Sample Collection and Handling Impact the Accuracy and Reliability of Blood Culture Tests
    • Growing Importance of Hospital-Acquired Infection Monitoring Expands Market Penetration for Blood Culture Testing
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Blood Culture Tests Market Analysis of Annual Sales in US$ Million for Years 2020 through 2032
    • TABLE 2: World Recent Past, Current & Future Analysis for Blood Culture Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 3: World Historic Review for Blood Culture Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 4: World 13-Year Perspective for Blood Culture Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2020, 2026 & 2032
    • TABLE 5: World Recent Past, Current & Future Analysis for Consumables Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 6: World Historic Review for Consumables Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 7: World 13-Year Perspective for Consumables Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 8: World Recent Past, Current & Future Analysis for Instruments Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 9: World Historic Review for Instruments Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 10: World 13-Year Perspective for Instruments Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 11: World Recent Past, Current & Future Analysis for Software & Services Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 12: World Historic Review for Software & Services Offering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 13: World 13-Year Perspective for Software & Services Offering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 14: World Recent Past, Current & Future Analysis for Culture-based Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 15: World Historic Review for Culture-based Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 16: World 13-Year Perspective for Culture-based Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 17: World Recent Past, Current & Future Analysis for Molecular Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 18: World Historic Review for Molecular Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 19: World 13-Year Perspective for Molecular Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 20: World Recent Past, Current & Future Analysis for Proteomic Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 21: World Historic Review for Proteomic Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 22: World 13-Year Perspective for Proteomic Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 23: World Recent Past, Current & Future Analysis for Bacterial Infections Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 24: World Historic Review for Bacterial Infections Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 25: World 13-Year Perspective for Bacterial Infections Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 26: World Recent Past, Current & Future Analysis for Fungal Infections Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 27: World Historic Review for Fungal Infections Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 28: World 13-Year Perspective for Fungal Infections Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 29: World Recent Past, Current & Future Analysis for Mycobacterial Infections Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 30: World Historic Review for Mycobacterial Infections Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 31: World 13-Year Perspective for Mycobacterial Infections Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 32: World Recent Past, Current & Future Analysis for Hospital Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 33: World Historic Review for Hospital Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 34: World 13-Year Perspective for Hospital Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 35: World Recent Past, Current & Future Analysis for Reference Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 36: World Historic Review for Reference Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 37: World 13-Year Perspective for Reference Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032
    • TABLE 38: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 39: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 40: World 13-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2020, 2026 & 2032

III. MARKET ANALYSIS

  • UNITED STATES
    • Blood Culture Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2026 (E)
    • TABLE 41: USA Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 42: USA Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 43: USA 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 44: USA Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 45: USA Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 46: USA 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 47: USA Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 48: USA Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 49: USA 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 50: USA Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 51: USA Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 52: USA 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • CANADA
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 54: Canada Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 55: Canada 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 56: Canada Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 57: Canada Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 58: Canada 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 60: Canada Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 61: Canada 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 63: Canada Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 64: Canada 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • JAPAN
    • Blood Culture Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2026 (E)
    • TABLE 65: Japan Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 66: Japan Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 67: Japan 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 69: Japan Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 70: Japan 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 72: Japan Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 73: Japan 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 75: Japan Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 76: Japan 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • CHINA
    • Blood Culture Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2026 (E)
    • TABLE 77: China Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 78: China Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 79: China 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 80: China Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 81: China Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 82: China 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 83: China Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 84: China Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 85: China 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 86: China Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 87: China Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 88: China 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • EUROPE
    • Blood Culture Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2026 (E)
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Blood Culture Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 90: Europe Historic Review for Blood Culture Tests by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 91: Europe 13-Year Perspective for Blood Culture Tests by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2020, 2026 & 2032
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 93: Europe Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 94: Europe 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 96: Europe Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 97: Europe 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 98: Europe Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 99: Europe Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 100: Europe 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 101: Europe Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 102: Europe Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 103: Europe 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • FRANCE
    • Blood Culture Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2026 (E)
    • TABLE 104: France Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 105: France Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 106: France 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 107: France Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 108: France Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 109: France 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 110: France Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 111: France Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 112: France 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 113: France Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 114: France Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 115: France 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • GERMANY
    • Blood Culture Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2026 (E)
    • TABLE 116: Germany Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 117: Germany Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 118: Germany 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 119: Germany Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 120: Germany Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 121: Germany 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 122: Germany Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 123: Germany Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 124: Germany 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 125: Germany Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 126: Germany Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 127: Germany 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • ITALY
    • TABLE 128: Italy Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 129: Italy Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 130: Italy 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 131: Italy Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 132: Italy Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 133: Italy 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 134: Italy Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 135: Italy Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 136: Italy 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 137: Italy Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 138: Italy Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 139: Italy 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • UNITED KINGDOM
    • Blood Culture Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2026 (E)
    • TABLE 140: UK Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 141: UK Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 142: UK 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 143: UK Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 144: UK Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 145: UK 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 146: UK Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 147: UK Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 148: UK 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 149: UK Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 150: UK Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 151: UK 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • SPAIN
    • TABLE 152: Spain Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 153: Spain Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 154: Spain 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 155: Spain Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 156: Spain Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 157: Spain 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 158: Spain Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 159: Spain Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 160: Spain 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 161: Spain Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 162: Spain Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 163: Spain 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • RUSSIA
    • TABLE 164: Russia Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 165: Russia Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 166: Russia 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 167: Russia Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 168: Russia Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 169: Russia 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 170: Russia Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 171: Russia Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 172: Russia 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 173: Russia Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 174: Russia Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 175: Russia 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • REST OF EUROPE
    • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 177: Rest of Europe Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 178: Rest of Europe 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 180: Rest of Europe Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 181: Rest of Europe 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 182: Rest of Europe Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 183: Rest of Europe Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 184: Rest of Europe 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 185: Rest of Europe Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 186: Rest of Europe Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 187: Rest of Europe 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • ASIA-PACIFIC
    • Blood Culture Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2026 (E)
    • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Blood Culture Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 189: Asia-Pacific Historic Review for Blood Culture Tests by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 190: Asia-Pacific 13-Year Perspective for Blood Culture Tests by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2020, 2026 & 2032
    • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 192: Asia-Pacific Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 193: Asia-Pacific 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 195: Asia-Pacific Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 196: Asia-Pacific 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 197: Asia-Pacific Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 198: Asia-Pacific Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 199: Asia-Pacific 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 200: Asia-Pacific Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 201: Asia-Pacific Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 202: Asia-Pacific 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • AUSTRALIA
    • Blood Culture Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2026 (E)
    • TABLE 203: Australia Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 204: Australia Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 205: Australia 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 206: Australia Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 207: Australia Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 208: Australia 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 209: Australia Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 210: Australia Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 211: Australia 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 212: Australia Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 213: Australia Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 214: Australia 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • INDIA
    • Blood Culture Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2026 (E)
    • TABLE 215: India Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 216: India Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 217: India 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 218: India Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 219: India Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 220: India 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 221: India Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 222: India Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 223: India 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 224: India Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 225: India Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 226: India 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • SOUTH KOREA
    • TABLE 227: South Korea Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 228: South Korea Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 229: South Korea 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 230: South Korea Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 231: South Korea Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 232: South Korea 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 233: South Korea Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 234: South Korea Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 235: South Korea 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 236: South Korea Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 237: South Korea Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 238: South Korea 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • REST OF ASIA-PACIFIC
    • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 240: Rest of Asia-Pacific Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 241: Rest of Asia-Pacific 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 243: Rest of Asia-Pacific Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 244: Rest of Asia-Pacific 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 245: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 246: Rest of Asia-Pacific Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 247: Rest of Asia-Pacific 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 248: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 249: Rest of Asia-Pacific Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 250: Rest of Asia-Pacific 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • LATIN AMERICA
    • Blood Culture Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2026 (E)
    • TABLE 251: Latin America Recent Past, Current & Future Analysis for Blood Culture Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 252: Latin America Historic Review for Blood Culture Tests by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 253: Latin America 13-Year Perspective for Blood Culture Tests by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2020, 2026 & 2032
    • TABLE 254: Latin America Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 255: Latin America Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 256: Latin America 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 257: Latin America Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 258: Latin America Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 259: Latin America 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 260: Latin America Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 261: Latin America Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 262: Latin America 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 263: Latin America Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 264: Latin America Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 265: Latin America 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • ARGENTINA
    • TABLE 266: Argentina Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 267: Argentina Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 268: Argentina 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 269: Argentina Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 270: Argentina Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 271: Argentina 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 272: Argentina Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 273: Argentina Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 274: Argentina 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 275: Argentina Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 276: Argentina Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 277: Argentina 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • BRAZIL
    • TABLE 278: Brazil Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 279: Brazil Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 280: Brazil 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 281: Brazil Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 282: Brazil Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 283: Brazil 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 284: Brazil Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 285: Brazil Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 286: Brazil 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 287: Brazil Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 288: Brazil Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 289: Brazil 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • MEXICO
    • TABLE 290: Mexico Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 291: Mexico Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 292: Mexico 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 293: Mexico Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 294: Mexico Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 295: Mexico 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 296: Mexico Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 297: Mexico Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 298: Mexico 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 299: Mexico Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 300: Mexico Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 301: Mexico 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • REST OF LATIN AMERICA
    • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 303: Rest of Latin America Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 304: Rest of Latin America 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 306: Rest of Latin America Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 307: Rest of Latin America 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 308: Rest of Latin America Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 309: Rest of Latin America Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 310: Rest of Latin America 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 311: Rest of Latin America Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 312: Rest of Latin America Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 313: Rest of Latin America 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • MIDDLE EAST
    • Blood Culture Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2026 (E)
    • TABLE 314: Middle East Recent Past, Current & Future Analysis for Blood Culture Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2025 through 2032 and % CAGR
    • TABLE 315: Middle East Historic Review for Blood Culture Tests by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 316: Middle East 13-Year Perspective for Blood Culture Tests by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2020, 2026 & 2032
    • TABLE 317: Middle East Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 318: Middle East Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 319: Middle East 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 320: Middle East Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 321: Middle East Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 322: Middle East 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 323: Middle East Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 324: Middle East Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 325: Middle East 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 326: Middle East Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 327: Middle East Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 328: Middle East 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • IRAN
    • TABLE 329: Iran Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 330: Iran Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 331: Iran 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 332: Iran Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 333: Iran Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 334: Iran 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 335: Iran Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 336: Iran Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 337: Iran 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 338: Iran Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 339: Iran Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 340: Iran 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • ISRAEL
    • TABLE 341: Israel Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 342: Israel Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 343: Israel 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 344: Israel Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 345: Israel Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 346: Israel 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 347: Israel Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 348: Israel Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 349: Israel 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 350: Israel Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 351: Israel Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 352: Israel 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • SAUDI ARABIA
    • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 354: Saudi Arabia Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 355: Saudi Arabia 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 357: Saudi Arabia Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 358: Saudi Arabia 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 359: Saudi Arabia Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 360: Saudi Arabia Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 361: Saudi Arabia 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 362: Saudi Arabia Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 363: Saudi Arabia Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 364: Saudi Arabia 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • UNITED ARAB EMIRATES
    • TABLE 365: UAE Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 366: UAE Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 367: UAE 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 368: UAE Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 369: UAE Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 370: UAE 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 371: UAE Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 372: UAE Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 373: UAE 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 374: UAE Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 375: UAE Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 376: UAE 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • REST OF MIDDLE EAST
    • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 378: Rest of Middle East Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 379: Rest of Middle East 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 381: Rest of Middle East Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 382: Rest of Middle East 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 383: Rest of Middle East Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 384: Rest of Middle East Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 385: Rest of Middle East 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 386: Rest of Middle East Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 387: Rest of Middle East Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 388: Rest of Middle East 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032
  • AFRICA
    • Blood Culture Tests Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2026 (E)
    • TABLE 389: Africa Recent Past, Current & Future Analysis for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 390: Africa Historic Review for Blood Culture Tests by Offering - Consumables Offering, Instruments Offering and Software & Services Offering Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 391: Africa 13-Year Perspective for Blood Culture Tests by Offering - Percentage Breakdown of Value Sales for Consumables Offering, Instruments Offering and Software & Services Offering for the Years 2020, 2026 & 2032
    • TABLE 392: Africa Recent Past, Current & Future Analysis for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 393: Africa Historic Review for Blood Culture Tests by Technology - Culture-based Technology, Molecular Technology and Proteomic Technology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 394: Africa 13-Year Perspective for Blood Culture Tests by Technology - Percentage Breakdown of Value Sales for Culture-based Technology, Molecular Technology and Proteomic Technology for the Years 2020, 2026 & 2032
    • TABLE 395: Africa Recent Past, Current & Future Analysis for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 396: Africa Historic Review for Blood Culture Tests by Application - Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 397: Africa 13-Year Perspective for Blood Culture Tests by Application - Percentage Breakdown of Value Sales for Bacterial Infections Application, Fungal Infections Application and Mycobacterial Infections Application for the Years 2020, 2026 & 2032
    • TABLE 398: Africa Recent Past, Current & Future Analysis for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2025 through 2032 and % CAGR
    • TABLE 399: Africa Historic Review for Blood Culture Tests by End-Use - Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2024 and % CAGR
    • TABLE 400: Africa 13-Year Perspective for Blood Culture Tests by End-Use - Percentage Breakdown of Value Sales for Hospital Laboratories End-Use, Reference Laboratories End-Use and Other End-Uses for the Years 2020, 2026 & 2032

IV. COMPETITION

×

원하시는 정보를 찾아 드릴까요?

보안문자 새로고침
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
email
문의하기